COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences to Present at the 2019 BIO CEO & Investor Conference

31/01/2019 - 14:30

NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]

Hemispherx Biopharma Shares CEO’s Presentation at the NobleConXV Conference

31/01/2019 - 14:30

OCALA, Fla., Jan. 31, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. CEO Tom Equels this week provided investors at NobleConXV with an update on the company’s ongoing work in immuno-oncology [...]

Catalyst Biosciences Announces Oral and Poster Presentations at the 12th Annual Congress of the European Association for Haemophilia and Allied Disorders

31/01/2019 - 14:30

Oral and poster presentations on updated interim data from the Phase 2/3 trial of MarzAA for the treatment of hemophilia A or B with inhibitors Poster presentation on preclinical data of CB 2679d-GT, Catalyst’s AAV- [...]

Cytori Cell Therapy™ Clinical Trial Results in Crohn’s Disease

31/01/2019 - 14:30

80% of Treated Patients with Clinical Response at 48 weeks, Published in Gastroenterology SAN DIEGO, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announces the publication of results from a [...]

Agritek Holdings, Inc. Announces Partnership Agreement with Colorado's Top Selling Cannabis Edibles Brand, Mountain High Suckers, for Puerto Rico Through Exclusive Licensee 1919 Clinic

31/01/2019 - 14:30

LOS ANGELES, CA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]

Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1

31/01/2019 - 14:30

First commercially available, automated single-cell analysis application to enable co-detection of cellular protein and RNA expression using microfluidics technology SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE [...]

CLS Holdings’ Oasis Dispensary Featured in February 2019 Edition of A&E Magazine as “Best Dispensary for Pot Pros”

31/01/2019 - 14:30

LAS VEGAS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc.’s (OTCQB: CLSH)(CSE: CLSH.U),“CLS”, Oasis dispensary is featured in the February 2019 edition of A&E Magazine as the “Best Dispensary for Pot Pros [...]

CareKinesis, a subsidiary of Tabula Rasa HealthCare, Signs New PACE Client in Arkansas

31/01/2019 - 14:05

Programs of All-inclusive Care for the Elderly Expanding in the State of Arkansas MOORESTOWN, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC) , a healthcare technology company [...]

HealthEC Awarded 2019 Best in KLAS Designation for Population Health

31/01/2019 - 14:01

Firm to be recognized at the KLAS Awards Reception during HIMSS19 in Orlando, Florida EDISON, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- HealthEC, LLC, an end-to-end provider of population health management solutions, [...]

Anavex Life Sciences to Announce Fiscal 2019 First Quarter Financial Results on Thursday, February 7th, 2019

31/01/2019 - 14:00

Conference Call and Webcast To be Held Thursday, February 7, 2019 4:30pm Eastern Time NEW YORK, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]

Chiesi USA, Inc. Receives Top Employer in the US Certification for 2019

31/01/2019 - 14:00

Top Employer Institute recognizes Chiesi USA for the fourth consecutive year CARY, N.C., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee) announced today that the company has been named as a Top Employer [...]

Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

31/01/2019 - 14:00

NEW YORK and CLEVELAND, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel cell and gene therapies for serious diseases, today [...]

Novo Nordisk A/S - Share repurchase programme

31/01/2019 - 13:52

Bagsværd, Denmark, 31 January 2019 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Spark Therapeutics Announces Presentation of Preclinical Data in Pompe Disease and CLN2 Disease at 15th Annual WORLDSymposium™

31/01/2019 - 13:30

PHILADELPHIA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today the [...]

Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City

31/01/2019 - 13:30

Invitation-only breakfast event sponsored by Onconova Therapeutics will also be webcast, beginning at 8:00 a.m. EST NEWTOWN, Pa., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX) , a Phase 3 [...]

Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer’s Disease

31/01/2019 - 13:30

Discontinued crenezumab phase 3 studies underscore urgent need for therapies that target the toxic oligomer with extraordinary precision TORONTO and CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- ProMIS [...]

Nash Pharmaceuticals to Present Pre-Clinical Data on Non-Alcoholic Fatty Liver Disease at 2nd Global NASH Congress in London, UK

31/01/2019 - 13:00

VANCOUVER, British Columbia, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) (the “ Company ” or “Nash Pharma”) is pleased to [...]

Agios to Webcast Conference Call of Fourth Quarter and Full Year 2018 Financial Results on February 14, 2019

31/01/2019 - 13:00

CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]

AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 7, 2019

31/01/2019 - 13:00

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]